Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-26

Clinical Trial Update: Rilpivirine in Virologically Suppressed Adolescents [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on rilpivirine for virologically suppressed adolescents, covering Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • rilpivirine (rilpivirine)

Snippet

Sponsor: Mahidol University | Conditions: HIV | Phase 2, Phase 3 | Status: UNKNOWN